DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Holdings Lessened by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC trimmed its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 4.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 28,417 shares of the medical instruments supplier’s stock after selling 1,279 shares during the quarter. Mutual of America Capital Management LLC’s holdings in DENTSPLY SIRONA were worth $1,011,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in DENTSPLY SIRONA by 1.5% in the third quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock worth $862,555,000 after buying an additional 369,213 shares during the last quarter. Invesco Ltd. increased its holdings in DENTSPLY SIRONA by 9.0% in the third quarter. Invesco Ltd. now owns 5,160,394 shares of the medical instruments supplier’s stock worth $176,279,000 after buying an additional 428,229 shares during the last quarter. Northern Trust Corp increased its holdings in DENTSPLY SIRONA by 6.6% in the third quarter. Northern Trust Corp now owns 2,802,131 shares of the medical instruments supplier’s stock worth $95,721,000 after buying an additional 173,627 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in DENTSPLY SIRONA by 0.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,885,223 shares of the medical instruments supplier’s stock worth $64,399,000 after buying an additional 6,890 shares during the last quarter. Finally, Armistice Capital LLC increased its holdings in DENTSPLY SIRONA by 1.5% in the third quarter. Armistice Capital LLC now owns 1,827,805 shares of the medical instruments supplier’s stock worth $62,438,000 after buying an additional 27,805 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Barrington Research restated an “outperform” rating and issued a $41.00 price objective on shares of DENTSPLY SIRONA in a report on Thursday, April 18th. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. SVB Leerink initiated coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an “outperform” rating and a $42.00 price target on the stock. Needham & Company LLC reiterated a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Finally, Piper Sandler increased their price target on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a report on Friday, January 12th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $39.50.

DENTSPLY SIRONA Trading Down 0.4 %

Shares of DENTSPLY SIRONA stock opened at $30.37 on Tuesday. The company’s fifty day simple moving average is $32.79 and its 200-day simple moving average is $32.84. The company has a market cap of $6.30 billion, a price-to-earnings ratio of -48.98, a PEG ratio of 1.23 and a beta of 0.98. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55. DENTSPLY SIRONA Inc. has a 1 year low of $26.27 and a 1 year high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. DENTSPLY SIRONA’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the company posted $0.46 earnings per share. As a group, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a yield of 2.11%. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -103.22%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.